Susanne R. T.
- Country
- Germany
- Department
- N/A
Research Overview
- N1T-MC-MALO: A Master Protocol for a Randomized, Controlled, Clinical Trial of Multiple Pharmacologic Agents in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease Who Are at Increased Risk of Developing Major Adverse Liver Outcomes (SYNERGY-Outcomes); N1T-MC-TZ01 Tirzepatide in participants with high-risk MASLD; N1T-MC-RT01 Retatrutide in participants with high-risk MASLD
- A Randomized, Placebo‑Controlled Trial of Zenagamtide (NNC0487‑0111) in Obese Patients with HFpEF or HFmrEF to Reduce CV Death and HF Hospitalization
- Efficacy and safety of zenagamtide once-weekly subcutaneous treatment for obesity in adults versus placebo
Data & Insights
Has run more than one trial at 447 of 1075 partner sites.
Specializations
Cardiovascular Health
The investigator specializes in studying preventive approaches for heart failure and reducing cardiovascular mortality. Their research involves evaluating combination therapies aimed at improving outcomes in patients at elevated cardiac risk.
- Heart Failure Prevention
- Cardiovascular Risk Management
- Combination Therapy Approaches
Their work focuses on innovative therapeutic strategies to protect cardiovascular health and prevent adverse cardiac events.
Metabolic Health
The investigator conducts research in the field of obesity management and related metabolic conditions. Their work encompasses therapeutic approaches for patients with obesity-related comorbidities.
- Weight Management
- Obesity Treatment
- Metabolic Disorders
The research activities center on developing effective interventions for weight reduction and managing weight-related health conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.